

[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI
[ Fri, Jul 17th 2020
] - WOPRAI

[ Thu, Jul 16th 2020
] - WOPRAI
[ Thu, Jul 16th 2020
] - WOPRAI
Steven Seedhouse Initiated (ARCT) at Buy and Held Target at $72 on, Jul 16th, 2020
Steven Seedhouse of Raymond James, Initiated "Arcturus Therapeutics Holdings Inc." (ARCT) at Buy and Held Target at $72 on, Jul 16th, 2020.
Steven has made no other calls on ARCT in the last 4 months.
There are 3 other peers that have a rating on ARCT. Out of the 3 peers that are also analyzing ARCT, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Stephen Brozak of "WBB Securities" Downgraded from Strong Buy to Hold and Held Target at $31 on, Tuesday, June 9th, 2020
These are the ratings of the 2 analyists that currently disagree with Steven
- Mayank Mamtani of "B. Riley Securities" Initiated at Strong Buy and Held Target at $70 on, Monday, July 13th, 2020
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $62 on, Tuesday, April 28th, 2020
Contributing Sources